37 related articles for article (PubMed ID: 38478383)
1. Investigating the relevance of CYP2J2 inhibition for drugs known to cause intermediate to high risk torsades de pointes.
Leow JWH; Gu Y; Chan ECY
Eur J Pharm Sci; 2023 Aug; 187():106475. PubMed ID: 37225005
[TBL] [Abstract][Full Text] [Related]
2. Anthracycline derivatives inhibit cardiac CYP2J2.
Kim JS; Arango AS; Shah S; Arnold WR; Tajkhorshid E; Das A
J Inorg Biochem; 2022 Apr; 229():111722. PubMed ID: 35078036
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948
[TBL] [Abstract][Full Text] [Related]
4. Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors.
Leow JWH; Verma RK; Lim ABH; Fan H; Chan ECY
Eur J Pharm Sci; 2021 Sep; 164():105889. PubMed ID: 34044117
[TBL] [Abstract][Full Text] [Related]
5. Investigating the association between CYP2J2 inhibitors and QT prolongation: a literature review.
Wiley AM; Yang J; Madhani R; Nath A; Totah RA
Drug Metab Rev; 2024; 56(2):145-163. PubMed ID: 38478383
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
Xu M; Ju W; Hao H; Wang G; Li P
Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
[TBL] [Abstract][Full Text] [Related]
7. CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control.
Leow JWH; Chan ECY
Pharmacol Ther; 2024 Jun; 258():108637. PubMed ID: 38521247
[TBL] [Abstract][Full Text] [Related]
8. The Role of Epoxyeicosatrienoic Acids in Cardiac Remodeling.
Lai J; Chen C
Front Physiol; 2021; 12():642470. PubMed ID: 33716791
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes.
Aliwarga T; Evangelista EA; Sotoodehnia N; Lemaitre RN; Totah RA
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966295
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity.
Solanki M; Pointon A; Jones B; Herbert K
Drug Metab Dispos; 2018 Aug; 46(8):1053-1065. PubMed ID: 29695613
[TBL] [Abstract][Full Text] [Related]
11. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
